Details for New Drug Application (NDA): 050767
✉ Email this page to a colleague
The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
Summary for 050767
Tradename: | CLEOCIN |
Applicant: | Pfizer |
Ingredient: | clindamycin phosphate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 050767
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 050767
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLEOCIN | clindamycin phosphate | SUPPOSITORY;VAGINAL | 050767 | NDA | Pharmacia & Upjohn Company LLC | 0009-7667 | 0009-7667-01 | 1 BLISTER PACK in 1 CARTON (0009-7667-01) / 3 SUPPOSITORY in 1 BLISTER PACK |
CLEOCIN | clindamycin phosphate | SUPPOSITORY;VAGINAL | 050767 | NDA | Pharmacia & Upjohn Company LLC | 0009-7667 | 0009-7667-05 | 1 BLISTER PACK in 1 CARTON (0009-7667-05) / 3 SUPPOSITORY in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUPPOSITORY;VAGINAL | Strength | 100MG | ||||
Approval Date: | Aug 13, 1999 | TE: | RLD: | Yes |
Expired US Patents for NDA 050767
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | CLEOCIN | clindamycin phosphate | SUPPOSITORY;VAGINAL | 050767-001 | Aug 13, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription